Study summary · 2021 · Randomized trial

HOME BP: supported self-monitoring in primary care

Supported home monitoring produced a modest additional reduction in systolic pressure.

Summary by Vironix Health · Source review: November 11, 2026
How we select and interpret evidence

Original publication

Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial

Richard J McManus; Paul Little; Beth Stuart; Katherine Morton; James Raftery; Jo Kelly; Katherine Bradbury; Jin Zhang; Shihua Zhu; Elizabeth Murray; Carl R May; Frances S Mair; Susan Michie; Peter Smith; Rebecca Band; Emma Ogburn; Julie Allen; Cathy Rice; Jacqui Nuttall; Bryan Williams; Lucy Yardley; HOME BP investigators

Universities of Oxford, Southampton, Bristol, Glasgow and University College London; London School of Hygiene and Tropical Medicine; UK primary-care practices

The BMJ · Online: · Issue: 2021

Journal article with 2022 correction, DOI 10.1136/bmj.m2216. · Full text consulted. This article has a linked published correction.

What was studied

Design
Randomized trial
Population
Adults with treated but poorly controlled hypertension and internet access
Sample
622 participants
Intervention
Home BP, digital feedback and clinician-directed medication titration
Comparator
Usual primary care
Follow-up
12 months
Setting
United Kingdom; 76 general practices

Methods

Unmasked randomized trial with automated primary-endpoint ascertainment.

Findings

Adjusted systolic BP difference at one year was −3.4 mmHg (95% CI −6.1 to −0.8). Adverse effects were similar.

Limitations

One-year BP measurements were available for 552 of 622 participants (88.6%); missing outcomes were imputed. Internet access was required, and the intervention bundled several components. A 2022 correction fixes baseline Table 1 counts.

What this means for care delivery

Plan clinical treatment responses and assisted access alongside home measurements.